Jyong Biotech Ltd. Ordina... (MENS)
NASDAQ: MENS
· Real-Time Price · USD
43.94
2.44 (5.88%)
At close: Aug 19, 2025, 1:46 PM
Company Description
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases.
The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Jyong Biotech Ltd. Ordinary Shares
| Country | TW |
| IPO Date | Jun 17, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Kuo Fu-Feng |
Contact Details
Address: 23F‑3, No. 95, Section 1, Xintai 5th Road New Taipei City, TW | |
| Website | https://www.jyongbio.com/ |
Stock Details
| Ticker Symbol | MENS |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | KYG831161065 |
| Employer ID | - |
| SIC Code | n/a |